5 Jun 2026Open access
Computational Identification of Natural Product-Derived GSK-3β Inhibitors as Candidate Therapeutics for Type 2 Diabetes and MASHPublisher siteResearch Square, Wnt/β-catenin signaling in development and cancer
Active, last published 2026
Ohilebo A.
Abass
Scholar“Research profile drawn from open scholarly records.”
Ambrose Alli University
Nigeria
Claim Your ProfileNigeria1
H-index
2
Citations
Ohilebo has not officially claimed their profile. If you are Ohilebo, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Ohilebo A. Abass will appear here once their profile is updated.
02 · Reach
Publication output and reach
Ohilebo's work has been cited 2 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchAmbrose Alli University, NigeriaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works23 Mar 2026Open access
Facilitators and barriers to dietary choices among older adults living in rural Edo, South-south, NigeriaPublisher sitemedRxiv, Child Nutrition and Water Access
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Ohilebo?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you